Related Experiment Videos
Refractory distal ulcerative colitis responsive to 5-aminosalicylate enemas
The American Journal of Gastroenterology
|August 1, 1985
Summary
For refractory distal ulcerative colitis, 5-aminosalicylate enemas offer a promising treatment. This topical therapy showed significant improvement in patients unresponsive to standard drugs.
Area of Science:
- Gastroenterology
- Internal Medicine
- Pharmacology
Background:
- Distal ulcerative colitis (UC) can be challenging to treat with standard therapies.
- 5-Aminosalicylate (5-ASA), the active component of sulfasalazine, demonstrates topical efficacy in new-onset distal colitis.
Observation:
- Six patients with distal colitis refractory to sulfasalazine and corticosteroids were studied.
- These patients received 5-aminosalicylate enemas as a therapeutic intervention.
Findings:
- A prompt and dramatic clinical response was observed in all six patients.
- Sigmoidoscopic and histological improvements corroborated the clinical findings.
- Topical 5-ASA enemas led to significant remission in refractory distal UC.
Implications:
- Topical 5-aminosalicylate enemas represent a valuable therapeutic option for refractory distal UC.
- This approach may improve outcomes for patients with limited response to conventional treatments.
- Further research into topical 5-ASA for refractory colitis is warranted.